Two Sigma Securities, LLC Penumbra Inc Call Options Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $499,583 - $649,455	-2,900 Reduced 39.19%	4,500 $809,000
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $1.08 Million - $1.34 Million	4,900 Added 196.0%	7,400 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$181.44 - $260.22 $1.16 Million - $1.67 Million	-6,400 Reduced 71.91%	2,500 $628,000
Q3 2023 Nov 14, 2023	BUY	$240.69 - $338.77 $601,725 - $846,925	2,500 Added 39.06%	8,900 $2.15 Million
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $1 Million - $1.27 Million	3,700 Added 137.04%	6,400 $2.2 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $595,161 - $752,463	2,700 New	2,700 $752,000
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $232,180 - $454,660	2,000 New	2,000 $249,000

375

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.94B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.